← All stocks

Elicio Therapeutics, Inc.

ELTX Net buying

CIK 0001601485 #4465 in the set updated 22 Sep 2026

Bought (120 mo)

$8.22M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$7.74M

$0.00 on a plan · $6.49M straight out of an exercise

Sold at will

$1.25M

28 of 30 sales

Net

+$471.53K

+$6.97M against sales at will

By person

15 insiders · 51 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Chudnovsky Yekaterina

Director

$7.05M (1)

—

+$7.05M

5,416,212

$31.47M

+670.8%

GANZI VICTOR F

Director

—

$3.95M (1) scheduled

−$3.95M

731,978

$4.25M

+35.0%

Venkatesan Jay

Director

$1.15M (9)

$2.55M (1) scheduled

−$1.40M

179,581

$1.04M

—

Goldberg Itzhak

Director

—

$1.15M (6)

−$1.15M

1,687,986

$9.81M

−19.8%

Rhodes Jennifer J

See Remarks

—

$62.43K (12)

−$62.43K

30,399

$176.62K

−14.8%

Neylan John F.

See Remarks

—

$40.43K (10)

−$40.43K

35,136

$204.14K

−9.7%

Nissenson Allen

Director

$10.93K (2)

—

+$10.93K

9,383

$54.52K

—

CURHAN GREGORY S

See Remarks

$9.48K (1)

—

+$9.48K

4,000

$23.24K

—

EISA-ABC LLC entity

10% owner

—

2,740,978

$15.93M

−25.0%

Connelly Robert

CEO, President and Director

—

120,570

$700.51K

+156.7%

OMENN GILBERT S

Director

—

80,326

$466.69K

+330.3%

Haqq Christopher

See Remarks

—

57,381

$333.38K

+79.4%

Shah Preetam

See Remarks

—

24,000

$139.44K

—

DeMuth Peter

Chief Scientific Officer

—

21,543

$125.16K

—

WILSON KAREN J

Director

—

18,718

$108.75K

—

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 10,791,326 to 26,281,882 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 114

Amendments (4/A) skipped 4

Filings about a different issuer 0

Unreadable filings 0

Joint filings 6

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 2

Sales at will 28

Transactions with no price 0

Shares from compensation/vesting 5,719,013

Sales filed before the plan box existed 28

History held since 8 Feb 2021